Skip to main content

Table 1 Basic characteristics of the included studies

From: The conservative management for improving Visual Analog Scale (VAS) pain scoring in greater trochanteric pain syndrome: a Bayesian analysis

Study

Country

Groups

Paintients

Age (years)

Follow-up

VAS (cm)

Begkas D, 2020 [25]

Athens

T: PRP-U C: CSI-U

24

48.7 (22-79)

24W

T: 1.52 ± 0.505 C: 6.98 ± 0.691

Bashkina A S, 2011 [26]

Russia

T: PRP-U C: CSI-U

40

T: 58.9 ± 7.9 C: 58.2 ± 8.1

6M

T: 0.43 ± 0.69 C: 4.55 ± 2.52

Ramon S, 2020 [27]

Spain

T: ESWT C: EX

100

T: 57.1 ± 12.9 C: 55.6 ± 13

2M

T: 2.0 ± 2.1 C: 4.7 ± 2.1

Furia J P, 2014 [28]

Germany

T: ESWT C: EX

32

T: 51.0 ± 9.9 C: 50.2 ± 14

12M

T: 2.7 ± 0.9 C: 6.3 ± 1.2

Shi L J, 2021 [29]

China

T: ESWT C: EX

53

T: 49.96 ± 6.39 C: 52.79 ± 5.86

6 M

T: 3.20±0.81 C: 6.3 ± 1.4

Heaver C, 2021 [30]

England

T: ESWT C: CSI-U

104

T: 63.73 ± 11.87 C: 60.31 ± 12.74

12M

T: 4.0±2.5 C: 4.82 ± 2.65

Mitchell W G, 2018 [31]

American

T: CSI-U C: CSI-B

30

T: 49.2 ± 12.0 C: 51.5 ± 15.4

6M

T: 1.3 ± 1.9 C: 2.2 ± 2.5

Brinks A, 2011 [32]

Netherlands

T: CSI-U C: UC

120

T: 57.7 ± 13.9 C: 54.8 ± 14.7

12M

At rest T1: 2.1 ± 2.5; C1: 2.3 ± 2.3 With activity T2: 2.8 ± 2.8; C3: 3.2 ± 2.9

  1. PRP-U ultrasound-guided platelet-rich plasma application, CSI-U ultrasound-guided corticosteroids injection, ESWT extracorporeal shockwave treatment, EX exercise, CSI-B corticosteroids injection under landmark, UC usual care